| |
| |
|
| Insider
Information: |
Bhavnagri Veer |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
556,049 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
556,049 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allogene Therapeutics, Inc. |
ALLO |
|
2023-03-14 |
556,049 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• • – |
2023-03-14 |
4 |
D |
$5.67 |
$133,971 |
D/D |
(23,628) |
556,049 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• • – |
2023-02-13 |
4 |
AS |
$6.85 |
$20,550 |
D/D |
(3,000) |
577,677 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• • – |
2023-01-17 |
4 |
AS |
$7.04 |
$21,120 |
D/D |
(3,000) |
580,677 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• • – |
2022-12-15 |
4 |
AS |
$7.53 |
$42,186 |
D/D |
(5,602) |
583,677 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2022-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
175,438 |
589,279 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2022-03-15 |
4 |
S |
$7.68 |
$67,962 |
D/D |
(8,849) |
413,841 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-09-15 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,669 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-09-15 |
4 |
AS |
$24.77 |
$123,845 |
D/D |
(5,000) |
421,669 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-08-16 |
4 |
AS |
$21.00 |
$104,994 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-08-16 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-07-15 |
4 |
AS |
$21.55 |
$107,753 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-07-15 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-05-18 |
4 |
AS |
$30.00 |
$150,000 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-05-18 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-05-17 |
4 |
AS |
$28.30 |
$141,476 |
D/D |
(5,000) |
421,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-05-17 |
4 |
OE |
$2.27 |
$11,350 |
D/D |
5,000 |
426,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-04-15 |
4 |
AS |
$32.01 |
$320,517 |
D/D |
(10,000) |
421,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-04-15 |
4 |
OE |
$2.27 |
$22,700 |
D/D |
10,000 |
431,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
22,202 |
421,353 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-03-15 |
4 |
AS |
$37.79 |
$630,798 |
D/D |
(16,623) |
399,151 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2021-03-15 |
4 |
OE |
$2.27 |
$22,700 |
D/D |
10,000 |
415,774 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2020-12-17 |
4 |
OE |
$2.27 |
$116,905 |
D/D |
51,500 |
405,402 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2020-10-06 |
4 |
OE |
$2.27 |
$22,700 |
D/D |
10,000 |
363,902 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2020-10-06 |
4 |
AS |
$40.00 |
$400,000 |
D/D |
(10,000) |
353,902 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
General Counsel |
• – – |
2020-10-01 |
4 |
AS |
$36.21 |
$912,913 |
D/D |
(25,000) |
353,902 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
